Fluidigm (NASDAQ:FLDM) Latest News, Stock Price and Trading Information

Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Globe Newswire 12-Feb 7:00 PM

Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results

Globe Newswire 7-Feb 4:05 PM

Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations

Globe Newswire 7-Feb 9:00 AM

Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases

Globe Newswire 7-Feb 8:30 AM

Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1

Globe Newswire 31-Jan 8:30 AM

Consolidated Research: 2019 Summary Expectations for Marriott International, Calavo Growers, Kinsale Capital Group, Fluidigm, Goldman Sachs BDC, and Stemline Therapeutics Fundamental Analysis, Key Performance Indications

Globe Newswire 24-Jan 7:55 AM

Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results

Globe Newswire 14-Jan 4:05 PM

Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring

Globe Newswire 8-Jan 8:31 AM

Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares

Globe Newswire 14-Dec 4:05 PM

Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock

Globe Newswire 12-Dec 1:01 AM

Fluidigm Announces Commencement of Public Offering of Common Stock

Globe Newswire 11-Dec 4:01 PM